Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles

Area of Science:

• Oncology
• Nanotechnology
• Gene Therapy

Background:

• Cancer remains a major global health challenge, with conventional treatments like chemotherapy and radiotherapy exhibiting suboptimal efficacy and significant side effects.
• Gene therapy presents a novel approach for cancer treatment, offering enhanced tumor targeting and potentially fewer adverse effects.
• Nucleic acid-based drugs, including small interfering RNA (siRNA), are gaining traction in cancer research for their therapeutic potential.

Purpose of the Study:

• To review the combination strategies of gene therapy with other cancer treatments.
• To highlight the critical role of nanoplatforms in delivering therapeutic agents for combined cancer therapies.
• To inspire innovative designs for combination therapies and identify future research directions.

Main Methods:

• Review of current literature on gene therapy, nanocarrier drug delivery, and combination cancer treatments.
• Analysis of synergistic effects achieved by combining gene therapy with phototherapy and magnetic hyperthermia therapy.
• Discussion of the role of nanoplatforms in facilitating these combined therapeutic modalities.

Main Results:

• Nanocarriers, such as liposomes, are effective in delivering gene therapy agents to tumor sites.
• Combining gene therapy with other modalities like phototherapy or magnetic hyperthermia can yield synergistic anticancer effects.
• Nanoplatforms are crucial for mediating these combined therapies, enhancing overall treatment efficacy.

Conclusions:

• Combination therapy using gene therapy and other modalities delivered via nanocarriers shows significant promise for improved cancer treatment.
• Addressing current bottlenecks and barriers in gene therapy is essential for achieving better clinical outcomes.
• Further research into nanoplatform design is needed to optimize combination cancer therapies.